SCHEMBL15076833

SCHEMBL15076833

NNCc1c(F)cccc1Cl

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 2/20 0.60
HTT P42858 3/20 0.57
RXFP1 Q9HBX9 1/20 0.56
ATM Q13315 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
GAA P10253 1/20 0.52
BACE1 P56817 1/20 0.49
MAPT P10636 2/20 0.48
KDM4E B2RXH2 2/20 0.48
ALDH1A1 P00352 1/20 0.48
MAPK1 P28482 1/20 0.48
MPI P34949 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
LCK P06239 2/20 0.46
BTK Q06187 2/20 0.46
MAPK14 Q16539 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL14120084 0.98 HTT (0.60) TAAR1HTTRXFP1ATMNPSR1
SCHEMBL8217518 0.87 TAAR1 (0.52) TAAR1HTTRXFP1NPSR1MEN1
SCHEMBL8223783 0.85 TAAR1 (0.43) TAAR1HTTRXFP1ATMNPSR1
SCHEMBL3935647 0.80 HTT (0.57) TAAR1HTTRXFP1ATMNPSR1
SCHEMBL19157555 0.80 HTT (0.57) TAAR1HTTRXFP1ATMNPSR1
SCHEMBL6701678 0.78 RXFP1 (0.72) TAAR1HTTRXFP1ATMNPSR1
SCHEMBL2221552 0.77 MEN1 (0.67) TAAR1HTTRXFP1ATMNPSR1
SCHEMBL113076 0.77 TAAR1 (0.73) TAAR1HTTRXFP1ATMNPSR1
SCHEMBL8225441 0.76 CD38 (0.39) TAAR1HTTRXFP1ATMNPSR1
SCHEMBL8065706 0.76 HTT (0.62) TAAR1HTTRXFP1ATMNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3312160-B1 HEPATITIS B ANTIVIRAL AGENTS NOVIRA THERAPEUTICS INC (US) 2020-03-18 EP disclosed
WO-2013096744-A1 HEPATITIS B ANTIVIRAL AGENTS NOVIRA THERAPEUTICS, INC. (US) 2013-06-27 WO disclosed